We are live on !
Find out more
HighMark Wealth Management Portfolio holdings
AUM
$299M
Turnover
13.67%
1-Year Est. Return
53.01%
This Fund
S&P 500
This Quarter Est. Return
+21.77%
1 Year Est. Return
+53.01%
3 Year Est. Return
+109.68%
5 Year Est. Return
+113.63%
10 Year Est. Return
–
AUM
$299M
AUM Growth
+$52.9M
(+22%)
Cap. Flow
+$8.26M
Cap. Flow % of AUM
Cap. Flow %
2.77%
Top 10 Holdings %
Top 10 Hldgs %
65.82%
Holding
600
New
46
Increased
156
Reduced
94
Closed
36
Avg Time Held
Equity + Options
3.4
years
Top 10 Avg Time Held
Equity + Options
2.7
years
Top 20 Avg Time Held
Equity + Options
2.3
years
Avg Time Held Equity only
3.4
years
Top 10 Avg Time Held Equity only
2.7
years
Top 20 Avg Time Held Equity only
2.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity MSCI Health Care Index ETF
FHLC
|
+$18.3M |
| 2 |
SI-BONE Inc
SIBN
|
+$3.79M |
| 3 |
Duos Technologies
DUOT
|
+$2.91M |
| 4 |
Apogee Therapeutics
APGE
|
+$2.91M |
| 5 |
Neuropace
NPCE
|
+$1.61M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CNTA
Centessa Pharmaceuticals
CNTA
|
+$9.41M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$5.14M |
| 3 |
AnaptysBio
ANAB
|
+$3.29M |
| 4 |
iShares MSCI EAFE Value ETF
EFV
|
+$1.64M |
| 5 |
Piper Sandler
PIPR
|
+$1.27M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 64.9% |
| 2 | Healthcare | 21.84% |
| 3 | Technology | 4.77% |
| 4 | Financials | 3.58% |
| 5 | Industrials | 1.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
iShares S&P 100 ETF
OEF
$20.3B
| $536K | 0.18% |
1,465
| – | – |
2019 Q4
26 quarters
|
|
52
Tandem Diabetes Care
TNDM
$1.21B
| $515K | 0.17% |
34,120
| – | – |
2019 Q4
26 quarters
|
|
53
KORU Medical Systems
KRMD
$145M
| $508K | 0.17% |
120,935
| – | – |
2019 Q4
26 quarters
|
|
54
Alphatec Holdings
ATEC
$1.74B
| $458K | 0.15% |
52,900
| – | – |
2021 Q1
21 quarters
|
|
55
Target
TGT
$69.8B
| $438K | 0.15% |
3,355
+27
| +0.8% | +$3.43K |
2019 Q4
26 quarters
|
|
56
Alphabet (Google) Class C
GOOG
$3.92T
| $435K | 0.15% |
1,230
+20
| +2% | +$7.15K |
2019 Q4
26 quarters
|
|
57
ExxonMobil
XOM
$754B
| $425K | 0.14% |
3,109
-30
| -1% | -$4.49K |
2019 Q4
26 quarters
|
|
58
Abbott
ABT
$178B
| $387K | 0.13% |
4,269
| – | – |
2019 Q4
26 quarters
|
|
59
Costco
COST
$447B
| $387K | 0.13% |
414
-24
| -5% | -$23.9K |
2019 Q4
26 quarters
|
|
60
Broadcom
AVGO
$1.56T
| $379K | 0.13% |
1,004
+135
| +16% | +$54.1K |
2022 Q2
16 quarters
|
|
61
Vanguard Morningstar Large-Cap ETF
VV
$54.1B
| $369K | 0.12% |
1,072
-80
| -7% | -$26.7K |
2019 Q4
26 quarters
|
|
62
Caterpillar
CAT
$316B
| $368K | 0.12% |
345
| – | – |
2019 Q4
26 quarters
|
|
63
Bridger Aerospace
BAER
$29.1M
| $365K | 0.12% |
220,162
+90,000
| +69% | +$178K |
2024 Q4
6 quarters
|
|
64
Palantir
PLTR
$471B
| $353K | 0.12% |
3,024
+311
| +11% | +$42.4K |
2024 Q1
9 quarters
|
|
65
Analog Devices
ADI
$189B
| $343K | 0.11% |
863
| – | – |
2023 Q1
13 quarters
|
|
66
HEICO Corp
HEI
$41.5B
| $322K | 0.11% |
904
| – | – |
2023 Q1
13 quarters
|
|
67
Invesco QQQ Trust
QQQ
$478B
| $320K | 0.11% |
434
+2
| +0.5% | +$1.38K |
2019 Q4
26 quarters
|
|
68
VanEck Semiconductor ETF
SMH
$64.3B
| $303K | 0.1% |
462
-33
| -7% | -$18K |
2025 Q3
3 quarters
|
|
69
UnitedHealth
UNH
$380B
| $299K | 0.1% |
720
-68
| -9% | -$25.2K |
2019 Q4
26 quarters
|
|
70
Micron Technology
MU
$1T
| $297K | 0.1% |
257
-14
| -5% | -$10.5K |
2020 Q4
22 quarters
|
|
71
iShares Core MSCI EAFE ETF
IEFA
$188B
| $289K | 0.1% |
2,991
-164
| -5% | -$15.8K |
2019 Q4
26 quarters
|
|
72
Colgate-Palmolive
CL
$75.1B
| $275K | 0.09% |
3,000
| – | – |
2025 Q2
4 quarters
|
|
73
IBM
IBM
$240B
| $272K | 0.09% |
967
+5
| +0.5% | +$1.26K |
2025 Q2
4 quarters
|
|
74
Johnson & Johnson
JNJ
$634B
| $247K | 0.08% |
972
+31
| +3% | +$7.22K |
2019 Q4
26 quarters
|
|
75
iShares Russell Mid-Cap ETF
IWR
$56.9B
| $240K | 0.08% |
2,173
| – | – |
2019 Q4
26 quarters
|
|
Similar funds
SIIL
HighMark Wealth Management's Q2 2026 Portfolio in Review
As of Q2 2026, HighMark Wealth Management held 600 positions worth $299M, up 22% from $246M the previous quarter. Its ten largest holdings account for 66% of the portfolio.
HighMark Wealth Management's Q2 2026 filing shows 46 new, 156 increased, 94 reduced and 36 closed positions. Its largest new stake was Duos Technologies: 289,884 shares worth $3.48M. The largest sale was Centessa Pharmaceuticals, an estimated $9.41M.
By sector, the portfolio is most concentrated in Miscellaneous at 65% of assets, down from 65% a quarter earlier, followed by Healthcare and Technology.
- HighMark Wealth Management's largest Q2 2026 buy was Duos Technologies: 289,884 shares worth $3.48M.
- HighMark Wealth Management added most to Fidelity MSCI Health Care Index ETF in Q2 2026, an estimated $18.3M increase.
- HighMark Wealth Management's biggest Q2 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $5.14M.
- HighMark Wealth Management fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $9.41M.
- HighMark Wealth Management's ten largest holdings make up 66% of its $299M portfolio in Q2 2026.
- HighMark Wealth Management opened 46 new positions and closed 36 in Q2 2026.
- HighMark Wealth Management's portfolio value rose 22% quarter-over-quarter to $299M.
Based on HighMark Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.